142 related articles for article (PubMed ID: 17490545)
21. Selective down-regulation of the NKG2D ligand H60 by mouse cytomegalovirus m155 glycoprotein.
Hasan M; Krmpotic A; Ruzsics Z; Bubic I; Lenac T; Halenius A; Loewendorf A; Messerle M; Hengel H; Jonjic S; Koszinowski UH
J Virol; 2005 Mar; 79(5):2920-30. PubMed ID: 15709011
[TBL] [Abstract][Full Text] [Related]
22. Expression of the RAE-1 family of stimulatory NK-cell ligands requires activation of the PI3K pathway during viral infection and transformation.
Tokuyama M; Lorin C; Delebecque F; Jung H; Raulet DH; Coscoy L
PLoS Pathog; 2011 Sep; 7(9):e1002265. PubMed ID: 21966273
[TBL] [Abstract][Full Text] [Related]
23. CBP/p300 acetyltransferases regulate the expression of NKG2D ligands on tumor cells.
Sauer M; Schuldner M; Hoffmann N; Cetintas A; Reiners KS; Shatnyeva O; Hallek M; Hansen HP; Gasser S; von Strandmann EP
Oncogene; 2017 Feb; 36(7):933-941. PubMed ID: 27477692
[TBL] [Abstract][Full Text] [Related]
24. IL-21 enhances tumor rejection through a NKG2D-dependent mechanism.
Takaki R; Hayakawa Y; Nelson A; Sivakumar PV; Hughes S; Smyth MJ; Lanier LL
J Immunol; 2005 Aug; 175(4):2167-73. PubMed ID: 16081783
[TBL] [Abstract][Full Text] [Related]
25. EAE tolerance induction with Hsp70-peptide complexes depends on H60 and NKG2D activity.
Galazka G; Jurewicz A; Orlowski W; Stasiolek M; Brosnan CF; Raine CS; Selmaj K
J Immunol; 2007 Oct; 179(7):4503-12. PubMed ID: 17878346
[TBL] [Abstract][Full Text] [Related]
26. NKG2D blockade facilitates diabetes prevention by antigen-specific Tregs in a virus-induced model of diabetes.
Van Belle TL; Ling E; Haase C; Bresson D; Ursø B; von Herrath MG
J Autoimmun; 2013 Feb; 40():66-73. PubMed ID: 22944096
[TBL] [Abstract][Full Text] [Related]
27. Blockade of NKG2D signaling prevents the development of murine CD4+ T cell-mediated colitis.
Ito Y; Kanai T; Totsuka T; Okamoto R; Tsuchiya K; Nemoto Y; Yoshioka A; Tomita T; Nagaishi T; Sakamoto N; Sakanishi T; Okumura K; Yagita H; Watanabe M
Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G199-207. PubMed ID: 17962357
[TBL] [Abstract][Full Text] [Related]
28. NKG2D-dependent activation of dendritic epidermal T cells in contact hypersensitivity.
Nielsen MM; Dyring-Andersen B; Schmidt JD; Witherden D; Lovato P; Woetmann A; Ødum N; Poulsen SS; Havran WL; Geisler C; Bonefeld CM
J Invest Dermatol; 2015 May; 135(5):1311-1319. PubMed ID: 25634359
[TBL] [Abstract][Full Text] [Related]
29. NKG2D-independent suppression of T cell proliferation by H60 and MICA.
Kriegeskorte AK; Gebhardt FE; Porcellini S; Schiemann M; Stemberger C; Franz TJ; Huster KM; Carayannopoulos LN; Yokoyama WM; Colonna M; Siccardi AG; Bauer S; Busch DH
Proc Natl Acad Sci U S A; 2005 Aug; 102(33):11805-10. PubMed ID: 16091471
[TBL] [Abstract][Full Text] [Related]
30. Two novel NKG2D ligands of the mouse H60 family with differential expression patterns and binding affinities to NKG2D.
Takada A; Yoshida S; Kajikawa M; Miyatake Y; Tomaru U; Sakai M; Chiba H; Maenaka K; Kohda D; Fugo K; Kasahara M
J Immunol; 2008 Feb; 180(3):1678-85. PubMed ID: 18209064
[TBL] [Abstract][Full Text] [Related]
31. Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation.
Asai O; Longo DL; Tian ZG; Hornung RL; Taub DD; Ruscetti FW; Murphy WJ
J Clin Invest; 1998 May; 101(9):1835-42. PubMed ID: 9576746
[TBL] [Abstract][Full Text] [Related]
32. Up-regulation of NK cell activating receptors following allogeneic hematopoietic stem cell transplantation under a lymphodepleting reduced intensity regimen is associated with elevated IL-15 levels.
Boyiadzis M; Memon S; Carson J; Allen K; Szczepanski MJ; Vance BA; Dean R; Bishop MR; Gress RE; Hakim FT
Biol Blood Marrow Transplant; 2008 Mar; 14(3):290-300. PubMed ID: 18275895
[TBL] [Abstract][Full Text] [Related]
33. The requirement for NKG2D in NK cell-mediated rejection of parental bone marrow grafts is determined by MHC class I expressed by the graft recipient.
Beilke JN; Benjamin J; Lanier LL
Blood; 2010 Dec; 116(24):5208-16. PubMed ID: 20736452
[TBL] [Abstract][Full Text] [Related]
34. Increased susceptibility to liver injury in hepatitis B virus transgenic mice involves NKG2D-ligand interaction and natural killer cells.
Chen Y; Wei H; Sun R; Dong Z; Zhang J; Tian Z
Hepatology; 2007 Sep; 46(3):706-15. PubMed ID: 17626270
[TBL] [Abstract][Full Text] [Related]
35. Intact NKG2D-independent function of NK cells chronically stimulated with the NKG2D ligand Rae-1.
Champsaur M; Beilke JN; Ogasawara K; Koszinowski UH; Jonjic S; Lanier LL
J Immunol; 2010 Jul; 185(1):157-65. PubMed ID: 20530257
[TBL] [Abstract][Full Text] [Related]
36. Natural killer cells recognize friend retrovirus-infected erythroid progenitor cells through NKG2D-RAE-1 interactions In Vivo.
Ogawa T; Tsuji-Kawahara S; Yuasa T; Kinoshita S; Chikaishi T; Takamura S; Matsumura H; Seya T; Saga T; Miyazawa M
J Virol; 2011 Jun; 85(11):5423-35. PubMed ID: 21411527
[TBL] [Abstract][Full Text] [Related]
37. Chimeric NKG2D receptor-bearing T cells as immunotherapy for ovarian cancer.
Barber A; Zhang T; DeMars LR; Conejo-Garcia J; Roby KF; Sentman CL
Cancer Res; 2007 May; 67(10):5003-8. PubMed ID: 17510432
[TBL] [Abstract][Full Text] [Related]
38. Regulation of cutaneous malignancy by gammadelta T cells.
Girardi M; Oppenheim DE; Steele CR; Lewis JM; Glusac E; Filler R; Hobby P; Sutton B; Tigelaar RE; Hayday AC
Science; 2001 Oct; 294(5542):605-9. PubMed ID: 11567106
[TBL] [Abstract][Full Text] [Related]
39. Abrogation of graft-vs.-leukemia activity after depletion of CD3+ T cells in a murine model of MHC-matched peripheral blood progenitor cell transplantation (PBPCT).
Uharek L; Glass B; Zeis M; Dreger P; Steinmann J; Löffler H; Schmitz N
Exp Hematol; 1998 Feb; 26(2):93-9. PubMed ID: 9472798
[TBL] [Abstract][Full Text] [Related]
40. NK cells contribute to the skin graft rejection promoted by CD4+ T cells activated through the indirect allorecognition pathway.
Ito A; Shimura H; Nitahara A; Tomiyama K; Ito M; Kanekura T; Okumura K; Yagita H; Kawai K
Int Immunol; 2008 Oct; 20(10):1343-9. PubMed ID: 18697765
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
